A major focus of our lab is engineering innovation for analysis of complex biological systems -- as is required to address questions important to both fundamental biological systems and applied clinical research. We employ a combination of approaches drawn from chemical engineering, mechanical engineering, and electrical engineering with strong foundations in biology, materials science, and analytical chemistry. In essence, we strive to advance the "mathematization" of biology & medicine.
We are part of the UC Berkeley Department of Bioengineering and the UC Berkeley/UCSF Graduate Group in Bioengineering. Our research includes design and development of instrumentation that exploits scale-dependent physics and chemistry. Our work accelerates development of bioanalytical methods, streamlines sample preparation strategies, improves biomarker validation studies, and advances clinical diagnostics.
Affiliations: QB3: The California Institute of Quantitative Biosciences, The Berkeley Stem Cell Center, The Berkeley Center for Emerging and Neglected Diseases, the Jacobs Institue of Design Innovation, and The Lawrence Berkeley National Laboratory.We interact with these Graduate Programs: Bioengineering, Chemical Biology , and Applied Science & Technology, as well as various engineering & chemistry programs.
The Herr Lab acknowledges the generous support of the Chan Zucekrberg Biohub, the NIH Biden Cancer Moonshot Program (NCI), the W.M. Keck Foundation, the Alfred P. Sloan Foundation, the UC Discovery Program, Eli Lilly & Company, Bio-Rad Laboratories, NSF COINS, the Hellman Family, QB3 & the Rogers Family Foundation, DARPA, the NAE/Keck Futures Initiative, the Siebel Stem Cell Institute, the Siebel Scholars Program, Novartis, the US Department of Defense (Breast Cancer Research Program), the Blum Center for Developing Economies, the National Science Foundation (NSF, CBET), the National Institutes of Health (NIH, Office of the Director, the Innovative Molecular Analysis Technologies program at NCI, NIBIB, and NIGMS), the NIH Center for Future Technologies for Cancer Care (CFTCC at Boston University), the UC Cancer Research Coordinating Committee, UC Berkeley Biology Faculty Research Funds (BFRF), the Chau Hoi Shuen Foundation Women in Science Program, & the UC Berkeley Bakar Fellows program.